Onconova Therapeutics, Inc. - FORM 10-K - EX-23.1 - EXHIBIT 23.1 - March 18, 2021

Attached files

file filename
EX-32.2 - EXHIBIT 32.2 - Onconova Therapeutics, Inc.tm211024d3_ex32-2.htm
EX-32.1 - EXHIBIT 32.1 - Onconova Therapeutics, Inc.tm211024d3_ex32-1.htm
EX-31.2 - EXHIBIT 31.2 - Onconova Therapeutics, Inc.tm211024d3_ex31-2.htm
EX-31.1 - EXHIBIT 31.1 - Onconova Therapeutics, Inc.tm211024d3_ex31-1.htm
EX-21.1 - EXHIBIT 21.1 - Onconova Therapeutics, Inc.tm211024d3_ex21-1.htm
EX-10.15.2 - EXHIBIT 10.15.2 - Onconova Therapeutics, Inc.tm211024d3_ex10-15d2.htm
10-K - 10-K - Onconova Therapeutics, Inc.tm211024-1_10k.htm

 

Exhibit 23.1

 

Consent of Independent Registered Public Accounting Firm

 

We consent to the incorporation by reference in the following Registration Statements:

 

(1)Registration Statement (Form S-8 No. 333-191161) pertaining to the Onconova Therapeutics, Inc. 2013 Equity Compensation Plan
(2)Registration Statement (Form S-8 No. 333-194228) pertaining to the Onconova Therapeutics, Inc. 2013 Equity Compensation Plan
(3)Registration Statement (Form S-8 No. 333-204210) pertaining to the Onconova Therapeutics, Inc. 2013 Equity Compensation Plan
(4)Registration Statement (Form S-8 No. 333-210694) pertaining to the Onconova Therapeutics, Inc. 2013 Equity Compensation Plan
(5)Registration Statement (Form S-8 No. 333-215575) pertaining to the Onconova Therapeutics, Inc. 2013 Equity Compensation Plan
(6)Registration Statement (Form S-8 No. 333-222400) pertaining to the Onconova Therapeutics, Inc. 2013 Equity Compensation Plan
(7)Registration Statement (Form S-8 No. 333-226199) pertaining to the Onconova Therapeutics, Inc. 2018 Omnibus Incentive Compensation Plan
(8)Registration Statement (Form S-8 No. 333-233410) pertaining to the Onconova Therapeutics, Inc. 2018 Omnibus Incentive Compensation Plan
(9)Registration Statement (Form S-3 No. 333-237844) of Onconova Therapeutics, Inc.
(10)Registration Statement (Form S-3 No. 333-230744) of Onconova Therapeutics, Inc.
(11)Registration Statement (Form S-1 No. 333-211769) of Onconova Therapeutics, Inc.
(12)Registration Statement (Form S-1 No. 333-222374) of Onconova Therapeutics, Inc.
(13)Registration Statement (Form S-1 No. 333-224315) of Onconova Therapeutics, Inc.
(14)Registration Statement (Form S-1 No. 333-234360) of Onconova Therapeutics, Inc.

 

of our report dated March 18, 2021, with respect to the consolidated financial statements of Onconova Therapeutics, Inc. included in this Annual Report (Form 10-K) for the year ended December 31, 2020.

 

  /s/ Ernst & Young LLP

 

Philadelphia, Pennsylvania

March 18, 2021

 

 

Onconova Therapeutics, Inc. Reports

Also read